✦ LIBER ✦

A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions

✍ Scribed by G.W. Stone; P.S. Teirstein; R. Rubenstein

Book ID: 114347189
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 36 KB
Volume: 11
Category: Article
ISSN: 1062-1458
DOI: 10.1016/s1062-1458(02)00810-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of revascularization w

Long-term outcome of revascularization with percutaneous coronary intervention in a series of patients with chronic total occlusion

✍ Asier Subinas; Jose Ramon Rumorso; Mario Sadaba; Jose Juan Onaindia; Miren Telle 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

TCT-278: Short- and long-term clinical o

TCT-278: Short- and long-term clinical outcomes after percutaneous coronary intervention in patients with chronic total occlusions: results from a multicenter, prospective study

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 99 KB

A Blinded, Randomized, Placebo-Controlle

A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease

✍ Martin B. Leon; Ran Kornowski; William E. Downey; Giora Weisz; Donald S. Baim; R 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place

87 SINGLE USE OF ROMIPLOSTIM THROMBOPOIE

87 SINGLE USE OF ROMIPLOSTIM THROMBOPOIETIN ANALOGUE IN SEVERE THROMBOCYTOPENIA FOR OUTPATIENT PERCUTANEOUS LIVER BIOPSY IN PATIENTS WITH CHRONIC LIVER DISEASE-A RANDOMIZED DOUBLE BLINDED PROSPECTIVE TRIAL

✍ P.P. Basu; T. Nair; S. Farhat; N. James Shah; M. Jafri; S. Foustin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Glucose-lipid ratio is a determinant of

Glucose-lipid ratio is a determinant of nitrogen balance during total parenteral nutrition in critically ill patients: a prospective, randomized, multicenter blind trial with an intention-to-treat analysis

✍ P. Boulétreau; D. Chassard; B. Allaouchiche; J. C. Dumont; C. Auboyer; M. Bertin 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 171 KB